Literature DB >> 31323244

Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs.

Jiangkang Xu1, Abdur Rauf Khan1, Manfei Fu1, Rujuan Wang1, Jianbo Ji1, Guangxi Zhai2.   

Abstract

The selective infiltration of cell membranes and tissue barriers often blocks the entry of most active molecules. This natural defense mechanism prevents the invasion of exogenous substances and limits the therapeutic value of most available molecules. Therefore, it is particularly important to find appropriate ways of membrane translocation and therapeutic agent delivery to its target site. Cell penetrating peptides (CPPs) are a group of short peptides harnessed in this condition, possessing a significant capacity for membrane transduction and could be exploited to transfer various biologically active cargoes into the cells. Since their discovery, CPPs have been employed for delivery of a wide variety of therapeutic molecules to treat various disorders including cranial nerve involvement, ocular inflammation, myocardial ischemia, dermatosis and cancer. The promising results of CPPs-derived therapeutics in various tumor models demonstrated a potential and worthwhile scope of CPPs in chemotherapy. This review describes the detailed description of CPPs and CPPs-assisted molecular delivery against various tissues and organs disorders. An emphasis is focused on summarizing the novel insights and achievements of CPPs in surmounting the natural membrane barriers during the last 5 years.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell penetrating peptides; Disorders; Membrane transduction; Therapeutic agents

Year:  2019        PMID: 31323244     DOI: 10.1016/j.jconrel.2019.07.020

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures.

Authors:  Inés Bouzón-Arnáiz; Yunuen Avalos-Padilla; Arnau Biosca; Omar Caño-Prades; Lucía Román-Álamo; Javier Valle; David Andreu; Diana Moita; Miguel Prudêncio; Elsa M Arce; Diego Muñoz-Torrero; Xavier Fernàndez-Busquets
Journal:  BMC Biol       Date:  2022-10-22       Impact factor: 7.364

2.  RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain.

Authors:  Jiangkang Xu; Xiaoye Yang; Jianbo Ji; Yuan Gao; Na Qiu; Yanwei Xi; Anchang Liu; Guangxi Zhai
Journal:  J Nanobiotechnology       Date:  2021-08-21       Impact factor: 10.435

Review 3.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

Review 4.  Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).

Authors:  Wararat Chiangjong; Somchai Chutipongtanate; Suradej Hongeng
Journal:  Int J Oncol       Date:  2020-07-10       Impact factor: 5.650

5.  Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.

Authors:  Jingping Geng; Xiangli Guo; Lidan Wang; Richard Q Nguyen; Fengqin Wang; Changbai Liu; Hu Wang
Journal:  Biomolecules       Date:  2020-02-02

6.  Enzymology of the pathway for ATP production by arginine breakdown.

Authors:  Tjeerd Pols; Shubham Singh; Cecile Deelman-Driessen; Bauke F Gaastra; Bert Poolman
Journal:  FEBS J       Date:  2020-05-05       Impact factor: 5.542

7.  Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA.

Authors:  Hongjia Zhang; Ke Men; Congbin Pan; Yan Gao; Jingmei Li; Sibei Lei; Guonian Zhu; Rui Li; Yuquan Wei; Xingmei Duan
Journal:  Int J Nanomedicine       Date:  2020-12-07

8.  Tumor Microenvironment-Responsive Shell/Core Composite Nanoparticles for Enhanced Stability and Antitumor Efficiency Based on a pH-Triggered Charge-Reversal Mechanism.

Authors:  Qiuhua Luo; Wen Shi; Puxiu Wang; Yu Zhang; Jia Meng; Ling Zhang
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

9.  PTD4 Peptide Increases Neural Viability in an In Vitro Model of Acute Ischemic Stroke.

Authors:  Jarosław Mazuryk; Izabela Puchalska; Kamil Koziński; Magdalena J Ślusarz; Jarosław Ruczyński; Piotr Rekowski; Piotr Rogujski; Rafał Płatek; Marta Barbara Wiśniewska; Arkadiusz Piotrowski; Łukasz Janus; Piotr M Skowron; Michał Pikuła; Paweł Sachadyn; Sylwia Rodziewicz-Motowidło; Artur Czupryn; Piotr Mucha
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 10.  Targeting Tumor Endothelial Cells with Nanoparticles.

Authors:  Yu Sakurai; Hidetaka Akita; Hideyoshi Harashima
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.